Related references
Note: Only part of the references are listed.Microsomal prostaglandin E synthase-1 is involved in the metabolic and cardiovascular alterations associated with obesity
Constanza Ballesteros-Martinez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials
Yi Chen et al.
CLINICAL RHEUMATOLOGY (2022)
The emerging role of cell senescence in atherosclerosis
Chang-Meng Wu et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
A longitudinal study over 40 years to study the metabolic syndrome as a risk factor for cardiovascular diseases
Lars Lind et al.
SCIENTIFIC REPORTS (2021)
Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy
Luna Jimenez-Castilla et al.
ANTIOXIDANTS (2021)
The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis
Yingrui Li et al.
SCIENTIFIC REPORTS (2021)
Synthetic Biology towards Improved Flavonoid Pharmacokinetics
Moon Sajid et al.
BIOMOLECULES (2021)
Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review
Ke Xuan Li et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)
The Potential Protective Effects of Diosmin on Streptozotocin-Induced Diabetic Cardiomyopathy in Rats
Tarek Mohamed Ali et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2020)
Dietary Polyphenols and Gene Expression in Molecular Pathways Associated with Type 2 Diabetes Mellitus: A Review
Gideon Gatluak Kang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation
Anastasia Poznyak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Combating atherosclerosis with targeted Diosmin nanoparticles-treated experimental diabetes
O. M. Hendawy et al.
INVESTIGATIONAL NEW DRUGS (2020)
The Coming Age of Flavonoids in the Treatment of Diabetic Complications
Teresa Caro-Ordieres et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis
Michal Wicinski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
Walter Masson et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Metabolism and pharmacological activities of the natural health-benefiting compound diosmin
Yizhou Zheng et al.
FOOD & FUNCTION (2020)
Important Flavonoids and Their Role as a Therapeutic Agent
Asad Ullah et al.
MOLECULES (2020)
Anticytokine Agents Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Paul M. Ridker
CIRCULATION RESEARCH (2019)
Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs? Ten Years of FDA Guidance Requirements to Evaluate Cardiovascular Risk
Cecilia C. Low Wang et al.
CIRCULATION (2019)
Hypermetabolism and impaired endothelium-dependent vasodilation in mesenteric arteries of type 2 diabetes mellitus db/db mice
Lene Arildsen et al.
DIABETES & VASCULAR DISEASE RESEARCH (2019)
Effects of diosmin and crocin on metabolic syndrome-associated cardio-vascular complications in rats
Rania El-Fawal et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2019)
Effect of Diosmin Administration in Patients with Chronic Venous Disorders on Selected Factors Affecting Angiogenesis
Marcin Feldo et al.
MOLECULES (2019)
Glucose and insulin levels are associated with arterial stiffness and concentric remodeling of the heart
Marcello Ricardo Paulista Markus et al.
CARDIOVASCULAR DIABETOLOGY (2019)
NLRP3 Inflammasome and Mineralocorticoid Receptors Are Associated with Vascular Dysfunction in Type 2 Diabetes Mellitus
Nathanne Santos Ferreira et al.
CELLS (2019)
Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction
Linda Alex et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017
Thomas R. Einarson et al.
CARDIOVASCULAR DIABETOLOGY (2018)
The Role of Advanced Glycation End Products in Diabetic Vascular Complications
Sang Youl Rhee et al.
DIABETES & METABOLISM JOURNAL (2018)
Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling
Aurelie Nguyen Dinh Cat et al.
SCIENTIFIC REPORTS (2018)
Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials
Stavros K. Kakkos et al.
INTERNATIONAL ANGIOLOGY (2018)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Metabolites of flavonoid compounds preserve indices of endothelial cell nitric oxide bioavailability under glucotoxic conditions
Y. Qian et al.
NUTRITION & DIABETES (2017)
Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes
Andrew O. Odegaard et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Clinical Update: Cardiovascular Disease in Diabetes Mellitus Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations
Cecilia C. Low Wang et al.
CIRCULATION (2016)
Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy
Sahabuddin Ahmed et al.
INFLAMMATION (2016)
Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications
Carlo Palombo et al.
VASCULAR PHARMACOLOGY (2016)
Cardiovascular safety of anti-diabetic drugs
R. Kumar et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2016)
Vascular injury in diabetic db/db mice is ameliorated by atorvastatin: role of Rac1/2-sensitive Nox-dependent pathways
Thiago Bruder-Nascimento et al.
CLINICAL SCIENCE (2015)
Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus
Marcondes Alves B. Silva et al.
CLINICAL SCIENCE (2015)
Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice
Iolanda Lazaro et al.
DIABETES (2015)
Editor's Choice - Management of Chronic Venous Disease Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
C. Wittens et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2015)
Suppressor of Cytokine Signaling 1-Derived Peptide Inhibits Janus Kinase/Signal Transducers and Activators of Transcription Pathway and Improves Inflammation and Atherosclerosis in Diabetic Mice
Carlota Recio et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Small Artery Remodeling in Obesity and Insulin Resistance
Ana M. Briones et al.
CURRENT VASCULAR PHARMACOLOGY (2014)
Modulation of nitric oxide by flavonoids
J. Duarte et al.
FOOD & FUNCTION (2014)
Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats
Thangarasu Silambarasan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum
Peter Gloviczki et al.
JOURNAL OF VASCULAR SURGERY (2011)
Cardiac remodeling at the population level -risk factors, screening, and outcomes
Ola Gjesdal et al.
NATURE REVIEWS CARDIOLOGY (2011)
Mesenteric Resistance Arteries in Type 2 Diabetic db/db Mice Undergo Outward Remodeling
Flavia M. Souza-Smith et al.
PLOS ONE (2011)
Recipes for creating animal models of diabetic cardiovascular disease
Willa Hsueh et al.
CIRCULATION RESEARCH (2007)
Activation of telomerase and expression of human telomerase reverse transcriptase in coronary atherosclerosis
SC Liu et al.
CARDIOVASCULAR PATHOLOGY (2005)
Endothelial factors and microvascular hypertensive disease
D Rizzoni et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2001)
Share Paper
